,0
symbol,SDGR
price,57.935
beta,0.0
volAvg,1372921
mktCap,4001037570
lastDiv,0.0
range,25.5-99.5
changes,5.245
companyName,Schrodinger Inc
currency,USD
cik,0001490978
isin,US80810D1037
cusip,80810D103
exchange,NasdaqGS
exchangeShortName,NASDAQ
industry,Health Information Services
website,https://www.schrodinger.com
description,"Schrodinger, Inc. provides computational software solutions for drug discovery to the biopharmaceutical industry. The Company operates through two segments: Software and Drug Discovery. The Software segment is focused on licensing the Companyâ€™s software for molecular discovery. The Drug Discovery segment is focused on building a portfolio of preclinical and clinical drug programs, internally and through collaborations. Its platform integrates solutions for predictive modeling, data analytics and collaboration. Its wholly-owned programs include SDGR1, SDGR2, SDGR3, SDGR4 and SDGR5. SDGR1 and SDGR2 drug discovery programs are focused on targets that mediate deoxyribonucleic acid (DNA) repair, cell cycle regulation, replication stress responses, and apoptosis, or programmed cell death. SDGR3, SDGR4 and SDGR5 drug discovery programs are focused on genetically-defined cancers."
ceo,Dr. Ramy Farid
sector,Healthcare
country,US
fullTimeEmployees,392
phone,15032991150
address,"120 WEST 45TH STREET, 17TH FLOOR"
city,New York City
state,NEW YORK
zip,10036
dcfDiff,
dcf,
image,https://financialmodelingprep.com/image-stock/SDGR.jpg
ipoDate,2020-02-06
defaultImage,True
